![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Bayer and Forschungszentrum Juelich agree on research collaboration
At the signing ceremony of the new research collaboration: Back row from left: Dr. Simone Gatzke, Forschungszentrum Juelich, Raphael Dumain, Dr. Isolde Häuser-Hahn and...
Drug Research
GSK presents positive results from phase III FULFIL study at ERS International Congress
GlaxoSmithKline plc and Innoviva, Inc announced the presentation of further data from the pivotal phase III FULFIL study with investigational closed triple combination therapy...
Drug Research
Boehringer Ingelheim enters research agreement with Saniona
Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, and Saniona, a leading biotech company in the field of ion channel drug discovery,...
Drug Research
Nymox Pharmaceutical Reports Successful New Long-Term Fexapotide Placebo Crossover Study Results
Nymox Pharmaceutical Corp is pleased to announce successful new study results from the long-term blinded placebo crossover group from the U.S. Phase 3 trials...
Drug Research
Researchers develop safer opioid painkiller from scratch
An international team of researchers - led by scientists at UC San Francisco, Stanford University, the University of North Carolina (UNC), and the Friedrich-Alexander...
Drug Research
ViiV Healthcare Begins Phase III Programme To Evaluate Two-drug Regimen For HIV-1 Treatment
ViiV Healthcare announced the start of a phase III programme to support regulatory filings for a two-drug regimen of dolutegravir (Tivicay®) and lamivudine (Epivir®)...
Drug Research
Shortage of estrogen drugs in US worries trans women: ‘It’s my peace of mind’
The two most popular injectables used to transition are disappearing from shelves as one awaits re-approval by the FDA, but other factors remain murky...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read